• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

An algorithm for treating chronic urticaria with omalizumab: dose interval should be individualized.

作者信息

Uysal Pınar, Eller Esben, Mortz Charlotte G, Bindslev-Jensen Carsten

机构信息

Department of Dermatology and Allergy Centre, Odense Research Center for Anaphylaxis, Odense University Hospital, University of Southern Denmark, DK-5000 Odense C, Denmark.

Department of Dermatology and Allergy Centre, Odense Research Center for Anaphylaxis, Odense University Hospital, University of Southern Denmark, DK-5000 Odense C, Denmark.

出版信息

J Allergy Clin Immunol. 2014 Mar;133(3):914-5.e2. doi: 10.1016/j.jaci.2013.10.015. Epub 2013 Dec 18.

DOI:10.1016/j.jaci.2013.10.015
PMID:24360324
Abstract
摘要

相似文献

1
An algorithm for treating chronic urticaria with omalizumab: dose interval should be individualized.一种使用奥马珠单抗治疗慢性荨麻疹的算法：给药间隔应个体化。
J Allergy Clin Immunol. 2014 Mar;133(3):914-5.e2. doi: 10.1016/j.jaci.2013.10.015. Epub 2013 Dec 18.
2
Monitoring omalizumab treatment efficacy in chronic urticaria by the basophil activation test.通过嗜碱性粒细胞活化试验监测奥马珠单抗治疗慢性荨麻疹的疗效。
Allergol Immunopathol (Madr). 2012 Nov-Dec;40(6):390-2. doi: 10.1016/j.aller.2011.09.009. Epub 2011 Dec 15.
3
Successful treatment of a bullous urticaria with omalizumab.用奥马珠单抗成功治疗大疱性荨麻疹。
Allergol Int. 2014 Sep;63(3):495-7. doi: 10.2332/allergolint.14-LE-0699.
4
Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis.奥马珠单抗治疗难治性慢性荨麻疹的疗效和起效时间：回顾性临床分析。
J Dermatol Sci. 2014 Jan;73(1):57-62. doi: 10.1016/j.jdermsci.2013.08.011. Epub 2013 Sep 3.
5
Omalizumab, an Anti-IgE mAb, receives approval for the treatment of chronic idiopathic/spontaneous urticaria.奥马珠单抗，一种抗 IgE mAb，获批用于治疗慢性特发性/自发性荨麻疹。
J Invest Dermatol. 2015 Jan;135(1):13-15. doi: 10.1038/jid.2014.362.
6
Omalizumab is effective in nonautoimmune urticaria.奥马珠单抗对非自身免疫性荨麻疹有效。
J Allergy Clin Immunol. 2011 May;127(5):1300-2. doi: 10.1016/j.jaci.2010.12.1085. Epub 2011 Feb 11.
7
Extraordinary response to omalizumab in a child with severe chronic urticaria.重度慢性荨麻疹患儿对奥马珠单抗的显著反应。
Eur Ann Allergy Clin Immunol. 2014 Jan;46(1):41-2.
8
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.一项奥马珠单抗单剂量、安慰剂对照、剂量范围研究，用于 H1 抗组胺药难治性慢性特发性荨麻疹患者。
J Allergy Clin Immunol. 2011 Sep;128(3):567-73.e1. doi: 10.1016/j.jaci.2011.06.010. Epub 2011 Jul 18.
9
Ligelizumab for Chronic Spontaneous Urticaria.利格司亭治疗慢性自发性荨麻疹。
N Engl J Med. 2019 Oct 3;381(14):1321-1332. doi: 10.1056/NEJMoa1900408.
10
Real-life experiences with omalizumab for the treatment of chronic urticaria.奥马珠单抗治疗慢性荨麻疹的真实临床经验。
Ann Allergy Asthma Immunol. 2014 Feb;112(2):170-4. doi: 10.1016/j.anai.2013.12.005. Epub 2013 Dec 28.

引用本文的文献

1
Prevalence, Clinical Manifestations, Treatment, and Clinical Course of Chronic Urticaria in Elderly: A Systematic Review.老年人慢性荨麻疹的患病率、临床表现、治疗及临床病程：一项系统评价
J Asthma Allergy. 2022 Oct 20;15:1455-1490. doi: 10.2147/JAA.S379912. eCollection 2022.
2
An Overview of Off-Label Use of Humanized Monoclonal Antibodies in Paediatrics.人源化单克隆抗体在儿科领域的超说明书使用概述。
Medicina (Kaunas). 2022 Apr 29;58(5):625. doi: 10.3390/medicina58050625.
3
High-dose non-sedating antihistamines are used insufficiently in chronic urticaria patients treated with omalizumab.
在接受奥马珠单抗治疗的慢性荨麻疹患者中，高剂量非镇静性抗组胺药的使用不足。
Clin Transl Allergy. 2021 Dec 11;11(10):e12085. doi: 10.1002/clt2.12085. eCollection 2021 Dec.
4
Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients.奥马珠单抗治疗儿童慢性荨麻疹的安全性和有效性。
Pediatr Allergy Immunol. 2021 May;32(4):720-726. doi: 10.1111/pai.13426. Epub 2021 Jan 18.
5
Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence.奥马珠单抗剂量递增治疗慢性自发性荨麻疹：真实世界证据概述。
Clin Rev Allergy Immunol. 2020 Aug;59(1):38-45. doi: 10.1007/s12016-020-08794-6.
6
Management problems in severe chronic inducible urticaria: Two case reports.重度慢性诱导性荨麻疹的管理问题：两例病例报告
Exp Ther Med. 2019 Aug;18(2):960-963. doi: 10.3892/etm.2019.7651. Epub 2019 Jun 10.
7
Effective treatment of different H1-antihistamine-refractory chronic urticaria phenotypes with omalizumab.奥马珠单抗对不同H1抗组胺药难治性慢性荨麻疹表型的有效治疗。
Turk Pediatri Ars. 2018 Dec 1;53(4):250-254. doi: 10.5152/TurkPediatriArs.2016.4042. eCollection 2018 Dec.
8
Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of "Real-world" Evidence.奥马珠单抗治疗青少年和成人慢性特发性（自发性）荨麻疹患者的获益和危害：“真实世界”证据的荟萃分析。
JAMA Dermatol. 2019 Jan 1;155(1):29-38. doi: 10.1001/jamadermatol.2018.3447.
9
Omalizumab for chronic urticaria in Latin America.奥马珠单抗用于拉丁美洲慢性荨麻疹的治疗。
World Allergy Organ J. 2016 Nov 23;9(1):36. doi: 10.1186/s40413-016-0127-y. eCollection 2016.
10
Effective treatment of different phenotypes of chronic urticaria with omalizumab: Case reports and review of literature.奥马珠单抗有效治疗慢性荨麻疹的不同表型：病例报告及文献综述
Int J Immunopathol Pharmacol. 2016 Jun;29(2):320-8. doi: 10.1177/0394632015623795. Epub 2016 Jan 4.